These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15298533)

  • 41. Development of ambulatory care pharmacist positions under financial constraints.
    Evoy K; Fischer J; Mably M
    Am J Health Syst Pharm; 2015 Aug; 72(16):1350-3. PubMed ID: 26246290
    [No Abstract]   [Full Text] [Related]  

  • 42. Economic evaluation of pharmacist-led medication reviews in residential aged care facilities.
    Hasan SS; Thiruchelvam K; Kow CS; Ghori MU; Babar ZU
    Expert Rev Pharmacoecon Outcomes Res; 2017 Oct; 17(5):431-439. PubMed ID: 28825502
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost reduction associated with restriction policy on dispensing intravenous esomeprazole in Lebanon.
    Nasser SC; Nassif JG; Mahfouz F
    Pharm World Sci; 2010 Dec; 32(6):707-10. PubMed ID: 21052835
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Agreement between pharmacists for problem identification: an initial quality measurement of cognitive services.
    LaFleur J; Larson BS; Gunning KM; Stoddard GJ; Madden C; Oderda L; Steinvoort C; Oderda GM
    Ann Pharmacother; 2009 Jul; 43(7):1173-80. PubMed ID: 19584393
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmaceutical services in Rio de Janeiro Municipality, Brazil: development regarding selected aspects from 2008 to 2014.
    Silva RM; Pereira NC; Mendes LV; Luiza VL
    Cien Saude Colet; 2016 May; 21(5):1421-32. PubMed ID: 27166892
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Payment Reform Meets Pharmacy Practice and Education Transformation.
    Trygstad T
    N C Med J; 2017; 78(3):173-176. PubMed ID: 28576954
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development and implementation of a pharmacist-delivered Medicare annual wellness visit at a family practice office.
    Thomas MH; Goode JV
    J Am Pharm Assoc (2003); 2014; 54(4):427-34. PubMed ID: 25063263
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
    Yu J; Shah BM; Ip EJ; Chan J
    J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacist-provided services and community pharmacist integration into a patient-centered medical home: A qualitative study of primary care clinic staff perceptions.
    Bates KA; Stafford RA; Teeter BS; Diemer T; Thomas JL; Curran GM
    J Am Pharm Assoc (2003); 2019; 59(4S):S6-S11.e1. PubMed ID: 31101441
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estimating the cost of the Medicare Pharmacist Services Coverage Act of 2001.
    Poole VH; Moran DW; Webb CE
    Pharmacotherapy; 2003 Aug; 23(8):955-65. PubMed ID: 12921241
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost-benefit and cost-savings analyses of antiarrhythmic medication monitoring.
    Snider M; Carnes C; Grover J; Davis R; Kalbfleisch S
    Am J Health Syst Pharm; 2012 Sep; 69(18):1569-73. PubMed ID: 22935939
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PharmacistCARE: description of a pharmacist care service and lessons learned along the way.
    Divine H; Nicholas A; Johnson CL; Perrier DG; Steinke DT; Blumenschein K
    J Am Pharm Assoc (2003); 2008; 48(6):793-802. PubMed ID: 19019810
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Medication therapy management: 10 years of experience in a large integrated health care system.
    Ramalho de Oliveira D; Brummel AR; Miller DB
    J Manag Care Pharm; 2010 Apr; 16(3):185-95. PubMed ID: 20331323
    [TBL] [Abstract][Full Text] [Related]  

  • 54. What Does Provider Status Mean for Pharmacists?
    Consult Pharm; 2015 Aug; 30(8):478-80. PubMed ID: 26260644
    [No Abstract]   [Full Text] [Related]  

  • 55. Pharmacist involvement in primary care improves hypertensive patient clinical outcomes.
    Sookaneknun P; Richards RM; Sanguansermsri J; Teerasut C
    Ann Pharmacother; 2004 Dec; 38(12):2023-8. PubMed ID: 15522983
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Legislation proposes adding pharmacist services to Medicare.
    Thompson CA
    Am J Health Syst Pharm; 2014 Apr; 71(8):606-7. PubMed ID: 24688029
    [No Abstract]   [Full Text] [Related]  

  • 57. Pharmacist services: insurance need not be the only answer.
    Winckler SC
    J Am Pharm Assoc (Wash); 2002; 42(6):826. PubMed ID: 12482003
    [No Abstract]   [Full Text] [Related]  

  • 58. [Doctors and pharmacists in the Piave Valley, 1540-1670].
    Bartolini D
    Gesch Reg; 2002; 11(1):61-79. PubMed ID: 19499608
    [No Abstract]   [Full Text] [Related]  

  • 59. [Do pharmacists and the state increase drug costs?].
    Kaesback W
    MMW Fortschr Med; 1999 Dec; 141(48):54. PubMed ID: 10766548
    [No Abstract]   [Full Text] [Related]  

  • 60. Key factors for sustainable integration of pharmacists in team-based primary care physician practices.
    Dombrowski SK; Bacci JL; Klatt PM; Osborne M; Castelli G; Burns A; Somma McGivney MA
    J Am Pharm Assoc (2003); 2019; 59(3):439-448.e1. PubMed ID: 30982772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.